Evolution of Real-World Treatment Patterns over Time in Patients with HER2-Negative Advanced Gastric Cancer: A Retrospective Database Cohort Study from Japan. (PubMed, Adv Ther) - Sep 12, 2026 - "Use of newly introduced first-line regimens for HER2-negative aGC in Japanese clinical practice has increased over time, with an increase in the overall DoT."
HEOR • Journal • Real-world evidence • Retrospective data • Gastric Cancer • Oncology • Solid Tumor • HER-2
|
|
Bruno Casaes Teixeira; Eiji Nishiyama; Shuichi Hironaka; Takaki Yoshikawa; Tsunehisa Yamamoto; Yorifumi Kikko; Yuko Matsuda; Yusuke Shinno; Yuya Kimijima
|